New cell therapy takes on hard-to-treat brain cancer
NCT ID NCT06254326
First seen Nov 01, 2025 · Last updated May 02, 2026 · Updated 26 times
Summary
This early-phase study tests a new treatment for adults with a type of brain tumor called oligodendroglioma that has come back or is growing. The treatment uses the patient's own immune cells (dendritic cells, T cells, and stem cells) combined with targeted drugs. The main goals are to see if this approach is safe and possible to deliver. Only 12 patients will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT OLIGODENDROGLIOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Florida Health Shands Hospital
Gainesville, Florida, 32610, United States
Conditions
Explore the condition pages connected to this study.